Calypso Biotech picks up Series A funding

Calypso Biotech, a Dutch developer of therapeutic antibodies for autoimmune diseases, has secured 20 million euros in Series A financing. The lead backers were Gilde Healthcare and Inkef Capital.

Source: Press Release